Asbjørn Christophersen1, Melinda Ráki1, Elin Bergseng1, Knut Ea Lundin2, Jørgen Jahnsen3, Ludvig M Sollid1, Shuo-Wang Qiao1. 1. Centre for Immune Regulation and Department of Immunology, University of Oslo and Oslo University Hospital - Rikshospitalet, Oslo, Norway. 2. Centre for Immune Regulation and Department of Immunology, University of Oslo and Oslo University Hospital - Rikshospitalet, Oslo, Norway ; Department of Transplantation Medicine, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital - Rikshospitalet, Oslo, Norway. 3. Department of Gastroenterology, Oslo University Hospital - Ullevål, Oslo, Norway.
Abstract
BACKGROUND: Diagnosing coeliac disease (CD) can be challenging, despite highly specific autoantibodies and typical mucosal changes in the small intestine. The T-cell response to gluten is a hallmark of the disease that has been hitherto unexploited in clinical work-up. OBJECTIVES: We aimed to develop a new method that directly visualizes and characterizes gluten-reactive CD4+ T cells in blood, independently of gluten challenge, and to explore its diagnostic potential. METHODS: We performed bead-enrichment of DQ2.5-glia-α1a and DQ2.5-glia-α2 tetramer+ cells in the blood of control individuals, treated (TCD) and untreated patients (UCD). We visualized these cells by flow cytometry, sorted them and cloned them. We assessed their specificity by antigen stimulation and re-staining with tetramers. RESULTS: We detected significantly more gliadin-tetramer+ CD4+ effector memory T cells (TEM) in UCD and TCD patients, compared to controls. Significantly more gliadin-tetramer+ TEM in the CD patients than in controls expressed the gut-homing marker integrin-β7. CONCLUSION: Quantification of gut-homing, gluten-specific TEM in peripheral blood, visualized with human leukocyte antigen (HLA) -tetramers, may be used to distinguish CD patients from healthy individuals. Easy access to gluten-reactive blood T cells from diseased and healthy individuals may lead to new insights on the disease-driving CD4+ T cells in CD.
BACKGROUND: Diagnosing coeliac disease (CD) can be challenging, despite highly specific autoantibodies and typical mucosal changes in the small intestine. The T-cell response to gluten is a hallmark of the disease that has been hitherto unexploited in clinical work-up. OBJECTIVES: We aimed to develop a new method that directly visualizes and characterizes gluten-reactive CD4+ T cells in blood, independently of gluten challenge, and to explore its diagnostic potential. METHODS: We performed bead-enrichment of DQ2.5-glia-α1a and DQ2.5-glia-α2 tetramer+ cells in the blood of control individuals, treated (TCD) and untreated patients (UCD). We visualized these cells by flow cytometry, sorted them and cloned them. We assessed their specificity by antigen stimulation and re-staining with tetramers. RESULTS: We detected significantly more gliadin-tetramer+ CD4+ effector memory T cells (TEM) in UCD and TCDpatients, compared to controls. Significantly more gliadin-tetramer+ TEM in the CDpatients than in controls expressed the gut-homing marker integrin-β7. CONCLUSION: Quantification of gut-homing, gluten-specific TEM in peripheral blood, visualized with human leukocyte antigen (HLA) -tetramers, may be used to distinguish CDpatients from healthy individuals. Easy access to gluten-reactive blood T cells from diseased and healthy individuals may lead to new insights on the disease-driving CD4+ T cells in CD.
Entities:
Keywords:
Blood test; T cells; celiac disease; diagnostic marker; diagnostics; gliadin; gluten; gluten reactivity; histology; human leukocyte antigen; immunology
Authors: James J Moon; H Hamlet Chu; Marion Pepper; Stephen J McSorley; Stephen C Jameson; Ross M Kedl; Marc K Jenkins Journal: Immunity Date: 2007-08-16 Impact factor: 31.745
Authors: Richard W Olaussen; Malin R Karlsson; Knut E A Lundin; Jørgen Jahnsen; Per Brandtzaeg; Inger N Farstad Journal: Gastroenterology Date: 2007-04-18 Impact factor: 22.682
Authors: K E Lundin; H Scott; T Hansen; G Paulsen; T S Halstensen; O Fausa; E Thorsby; L M Sollid Journal: J Exp Med Date: 1993-07-01 Impact factor: 14.307
Authors: Gautam Goel; Tim King; A James Daveson; Jane M Andrews; Janakan Krishnarajah; Richard Krause; Gregor J E Brown; Ronald Fogel; Charles F Barish; Roger Epstein; Timothy P Kinney; Philip B Miner; Jason A Tye-Din; Adam Girardin; Juha Taavela; Alina Popp; John Sidney; Markku Mäki; Kaela E Goldstein; Patrick H Griffin; Suyue Wang; John L Dzuris; Leslie J Williams; Alessandro Sette; Ramnik J Xavier; Ludvig M Sollid; Bana Jabri; Robert P Anderson Journal: Lancet Gastroenterol Hepatol Date: 2017-05-11
Authors: Shiva Dahal-Koirala; Laura Ciacchi; Jan Petersen; Louise Fremgaard Risnes; Ralf Stefan Neumann; Asbjørn Christophersen; Knut E A Lundin; Hugh H Reid; Shuo-Wang Qiao; Jamie Rossjohn; Ludvig M Sollid Journal: J Biol Chem Date: 2018-11-19 Impact factor: 5.157
Authors: Louise F Risnes; Asbjørn Christophersen; Shiva Dahal-Koirala; Ralf S Neumann; Geir K Sandve; Vikas K Sarna; Knut Ea Lundin; Shuo-Wang Qiao; Ludvig M Sollid Journal: J Clin Invest Date: 2018-05-14 Impact factor: 14.808
Authors: Stephanie Zühlke; Louise Fremgaard Risnes; Shiva Dahal-Koirala; Asbjørn Christophersen; Ludvig M Sollid; Knut Ea Lundin Journal: United European Gastroenterol J Date: 2019-09-07 Impact factor: 4.623
Authors: S Dahal-Koirala; L F Risnes; A Christophersen; V K Sarna; K Ea Lundin; L M Sollid; S W Qiao Journal: Mucosal Immunol Date: 2016-02-03 Impact factor: 7.313